Article
The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability.
American journal of surgery - 1 Jun 1999
Kobayashi S, Koide Y, Endo M, Isono K, Ochiai T
Abstract excerpt
BACKGROUND: The p53 gene alteration is identified in approximately half of all human tumors, and is now thought to be a key gene for regulating the cell cycle through the induction of p21(WAF1/CIP1) and inducing apoptosis through some genes such as BAX. In this study, we investigated the prognostic value of p53 mutation for postoperative esophageal squamous cell carcinoma patients. METHODS: The subjects studied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
